Table 3.
Limited-Stage Disease | Extensive-Stage Disease | |||
---|---|---|---|---|
| ||||
Hazard Ratio (95% CI) N=288 |
Hazard Ratio (95% CI) N=643 |
|||
| ||||
Age at diagnosis | ||||
<60 | Ref | Ref | ||
60–69 | 1.30 (0.44, 3.79) | 1.31 (0.91, 1.88) | ||
70–79 | 2.16 (0.91, 5.14) | 1.66 (1.12, 2.45) | ||
80+ | 1.81 (0.66, 4.97) | 1.32 (0.84, 2.07) | ||
| ||||
Sex | ||||
Male | Ref | Ref | ||
Female | 0.96 (0.54, 1.73) | 0.67 (0.51, 0.90) | ||
| ||||
Race/Ethnicity | ||||
White | Ref | Ref | ||
Black | 0.41 (0.17, 0.94) | 1.16 (0.90, 1.49) | ||
Hispanic | 0.59 (0.24, 1.46) | 0.73 (0.52, 1.02) | ||
Other/Unknown | 0.33 (0.14, 0.75) | 0.79 (0.52, 1.20) | ||
| ||||
Insurance | ||||
Private | Ref | Ref | ||
Any Medicaid | 1.10 (0.42, 2.85) | 0.91 (0.63, 1.33) | ||
Medicare only | 0.81 (0.41, 1.60) | 1.48 (1.06, 2.06) | ||
IHS/Tricare/VA/Military | 1.80 (0.49, 6.61) | 0.98 (0.42, 2.30) | ||
Unknown/No Insurance | 0.71 (0.20, 2.51) | 1.28 (0.68, 2.41) | ||
| ||||
Charlson Comorbidity Score | ||||
0 | 0.48 (0.24, 0.96) | 1.03 (0.76, 1.41) | ||
1 | Ref | Ref | ||
2+ | 0.89 (0.47, 1.70) | 1.15 (0.74, 1.78) | ||
| ||||
Pneumonia/Lung Collapse | ||||
No/Unknown | Ref | Ref | ||
Yes | 1.41 (0.73, 2.70) | 1.50 (1.12, 2.01) | ||
| ||||
Treating Hospital Characteristics | ||||
| ||||
Residency Program | ||||
No/Unknown | Ref | Ref | ||
Yes | 1.84 (1.00, 3.36) | 0.76 (0.57, 1.00) | ||
| ||||
Hospital Ownership | ||||
Not-for-profit | Ref | Ref | ||
For Profit | 0.78 (0.30, 2.00) | 0.87 (0.53, 1.44) | ||
Government/Other | 0.79 (0.36, 1.72) | 0.94 (0.67, 1.32) | ||
| ||||
Treatment | ||||
No or unknown treatment | 16.12 (7.89, 32.95) | 5.45 (3.71, 8.01) | ||
RT only | 11.66 (5.09, 26.67) | 3.60 (2.33, 5.58) | ||
Any Chemo only | 1.79 (0.59, 5.49) | Ref | ||
Any Chemo & RT | Ref | 0.80 (0.55, 1.16) | ||
| ||||
Overall-Unadjusted 12-Month Mortality | 43.3% (N=129) | 72.5% (N=469) |